Crescent Biopharma (CBIO) Earnings Date & Reports

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CBIO is expected to report earnings to rise 32.86% to -93 cents per share on July 30

Crescent Biopharma CBIO Stock Earnings Reports

Q2'26

Est.

$-0.93

Q1'26

Beat

by $0.18

Q1'25

Beat

by $0.10

The last earnings report on April 29 showed earnings per share of -69 cents, beating the estimate of -87 cents. With 43.92K shares outstanding, the current market capitalization sits at 476.49M.

View a ticker or compare two or three

Compare

CBIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CBIO